Management of antithrombotic agents for endoscopic procedures

Management of antithrombotic agents for endoscopic procedures

This is one of a series of statements discussing the use of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for
Gastrointestinal Endoscopy (ASGE) prepared this text.

This guideline combines and updates 2 previously issued guidelines, ‘‘Guideline on the management of antithrombotic and antiplatelet therapy for endoscopic procedures’’
1 and ‘‘ASGE guideline: the management of lowmolecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures.’’2 To prepare this guideline, a search of the medical literature was performed using PubMed. Studies or reports that described fewer than 10 patients were excluded from analysis if multiple series with more than 10 patients addressing the same issue were available. Additional references
were obtained from the bibliographies of the identified articles and from recommendations of expert consultants.

Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus at the time the guidelines are drafted. Further
controlled clinical studies may be needed to clarify aspects of this guideline. This guideline may be revised as necessary to account for changes in technology, new
data, or other aspects of clinical practice. The recommendations are based on reviewed studies and were graded on the strength of the supporting evidence
(Table 1).3 The strength of individual recommendations is based on both the aggregate evidence quality and an assessment of the anticipated benefits and harms. Weaker
recommendations are indicated by phrases such as ‘‘we suggest,’’ whereas stronger recommendations are typically stated as ‘‘we recommend.’’

open here please to see the full-text:
http://www.asge.org/uploadedFiles/Publications_and_Products/Practice_Guidelines/PIIS0016510709025498.pdf